Prof. Rebekka Schneider is a Founder of Sequantrix^TM. She is a hematopathologist with strong background in clinical hematopathology and basic research. Rebekka is a Full Professor (W3) and Director of the Institute for Cell and Tumor Biology at the University Hospital RWTH Aachen, Germany. She is an international opinion leader and inventor in the field of myelofibrosis and awardee of 2 ERC grants and multiple awards and prizes.